English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 110944/141864 (78%)
Visitors : 48018656      Online Users : 785
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/140204


    Title: 全民健保制度下新藥上市行銷策略之探討-以減敏舌下錠藥物為例
    Marketing Strategies for New Product Launch under National Health Insurance System in Taiwan - The Study Focus on the Medicine of the Oral Immunotherapy
    Authors: 李克繼
    Lei, Daniel
    Contributors: 周冠男
    Chou, Robin K.
    李克繼
    Lei, Daniel
    Keywords: 新藥上市
    全民健康保險
    行銷4P
    New drug launch
    National Health Insurance
    PEST
    STP
    Marketing mix
    Date: 2022
    Issue Date: 2022-06-01 16:28:22 (UTC+8)
    Abstract: 台灣的全民健康保險聞名世界,許多國家皆來台取經與學習,在此制度下,新藥上市的規劃方式是否有所不同?本文以個案新藥為例,從全民健保制度切入分析,再分析特定疾病之市場需求,並利用PEST、STP、行銷4P分析工具,從不同角度分析下,整理出新藥上市所面臨的機會與挑戰,再擬定出新藥上市行銷策略與戰術,並歸納出四點結論。
    PEST、STP、行銷4P分析工具是基礎又有效的分析工具,適合應用在新藥上市規劃,在PEST分析中,先從政治與經濟的因素來評估新藥健保價與規模、利用STP分析結果,配合內部條件,決定細分市場的開發順序、4P分析中,先作價格分析,評估新藥的新藥的自費價與健保價,再作通路分析找出最適的通路覆蓋率。
    Taiwan’s national health insurance is famous in the world. Many experts from different countries have come to Taiwan and learn from it. Is there any difference to launch a new drug under Taiwan NHI system? This paper is starting from NHI system analysis, unmet need analysis to specific disease and leverage analysis tools (PEST/STP/marketing mix) to identify the opportunities and challenges. Based on the opportunities, develop marketing strategies and tactics of new drug. Finally, summarize four conclusions for new drug launch in Taiwan.
    PEST, STP, and marketing mix are basic and effective analysis tools suitable for marketing planning of new drug launch. For PEST analysis, first step is to evaluate NHI price and scale of new drug by analyzing political and economic factors. Determining target segments by STP analysis results and company capability.
    For marketing mix analysis, first step is to analyze the price of out-of-pocket and NHI price of new drugs, then find the most appropriate channel coverage by conduct channel analysis.
    Reference: 參考文獻

    中文部分

    政府公開資訊
    2020-2021全民健康保險年報
    國情統計通報第225號
    法規命令
    全民健康保險藥物給付項目及支付標準
    全民健保藥價調整作業辦法

    學位論文
    許富德,國際性大藥廠如何成功上市新產品,國立臺灣大學高階公共管理組碩士論文,民國94年

    書籍
    作詹哲豪/朱俊興,健檢報告完全手冊-居家自我健康管理手冊,晨星出版有限公司

    網路資料
    衛生福利部健保署
    維基百科,歐洲室塵蟎
    花蓮慈濟 MAST Allergy過敏原檢測
    高雄榮總張國平醫師,榮光雙週刊,惱人鼻塞

    英文部分

    期刊論文
    Jiu-Yao Wang, The innate immune response in house dust mite-induced allergic inflammation, Allergy Asthma Immunol Res. 2013; 5(2): 68-74.
    Jean B. et al, 2019 ARIA Care pathways for allergen immunotherapy, Allergy. 2019; 74:
    2087–2102.
    Jean B. et al, Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines, J Allergy
    Clin Immunol . 2001 Nov;108(5 Suppl):S147-334.
    Cezmi A. et al, Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs,
    J Clin Invest. 2004 Nov 15; 114(10): 1389–1397.
    Alvaro‐Lozano M et al, EAACI Allergen Immunotherapy User`s Guide, Pediatric
    Allergy and Immunology 31 (Suppl. 25) (2020) 1–101.
    Description: 碩士
    國立政治大學
    經營管理碩士學程(EMBA)
    106932123
    Source URI: http://thesis.lib.nccu.edu.tw/record/#G0106932123
    Data Type: thesis
    DOI: 10.6814/NCCU202200428
    Appears in Collections:[經營管理碩士學程EMBA] 學位論文

    Files in This Item:

    File Description SizeFormat
    212301.pdf2884KbAdobe PDF20View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback